DERM position history
The shares of Journey Medical (DERM) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2022 Q1: 67,000 shares, $324K, 0.10% of portfolio, New
- 2022 Q2: 245,733 shares, $919K, 0.41% of portfolio, Add +266.8%
- 2022 Q3: 259,293 shares, $638K, 0.26% of portfolio, Add +5.5%
- 2022 Q4: not held, Exit
- 2023 Q1: not held
- 2023 Q2: not held
- 2023 Q3: not held
- 2023 Q4: not held
- 2024 Q1: not held
- 2024 Q2: not held
- 2024 Q3: not held
- 2024 Q4: not held
- 2025 Q1: 69,323 shares, $409K, 0.09% of portfolio, New
- 2025 Q2: 190,000 shares, $1.4M, 0.27% of portfolio, Add +174.1%
- 2025 Q3: 971,064 shares, $6.9M, 0.98% of portfolio, Add +411.1%
- 2025 Q4: 1,950,000 shares, $15M, 2.0% of portfolio, Add +100.8%
- 2026 Q1: 960,000 shares, $4.5M, 0.59% of portfolio, Reduce −50.8%
- 2026 Q2: 350,000 shares, $2.5M, 0.22% of portfolio, Reduce −63.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|